A practical approach to process and analytical tech transfer that reduces risk, protects timelines, and supports IND and early clinical supply.
Tech transfer is often described as a handoff. In reality, it’s an end-to-end integration exercise: aligning process intent, analytical readiness, raw materials, equipment fit, documentation, and quality systems so manufacturing can execute consistently. When tech transfer is treated as a late-stage task, teams tend to discover gaps at the worst possible time—during engineering runs or GMP execution. At Avid, we approach tech transfer as a managed, data-driven program designed to preserve what works, clarify what’s changing, and keep the CMC narrative cohesive as you move toward IND filing and early clinical supply.
A 6‑month tech transfer process
When tech transfer is done right, timelines don’t just improve—they become predictable.
At Avid, we’ve demonstrated tech transfer timelines as fast as ~6 months, enabled by our integrated model.
Unlike traditional approaches that rely on sequential steps, this model enables:
- Parallel preparation of GMP systems and documentation
- Early identification and mitigation of process risks
- Faster progression into engineering and GMP runs
What “successful” tech transfer really means
- Process intent is explicit: critical parameters, acceptable ranges, and known sensitivities are documented and understood by receiving teams.
- Analytics are manufacturing-ready: methods are qualified/validated to the right phase-appropriate level, with clear system suitability and sampling plans.
- Materials and equipment are aligned: raw material attributes, single-use assemblies, and equipment mapping are confirmed early to avoid late changes.
- Quality is embedded: deviations, change control, and documentation practices are harmonized so execution and review are predictable.
- Comparability is planned: when changes are necessary, the strategy (and required data) is defined before runs begin.
Video: Avid’s tech transfer webinar presented by Rich Richieri, COO, shares a practical, experience-driven framework for successfully transferring biologics processes and advancing them through process performance qualification at scale.
Common tech transfer risks—and how to reduce them
Most tech transfer delays trace back to a handful of themes: unclear “source” knowledge (tribal expertise that isn’t captured), analytical methods that aren’t robust across sites, supply chain substitutions made too late, and documentation that doesn’t match how the process is actually run. De-risking starts with a structured gap assessment, followed by a transfer plan that assigns owners and due dates across functions. Just as important: running the right execution sequence (e.g., paper exercise → feasibility/fit runs → engineering runs → GMP) so each step closes a defined set of open questions.
Tech transfer and onshoring: building resilience without breaking the timeline
For many sponsors, tech transfer is happening alongside a broader manufacturing strategy shift—especially onshoring to improve supply security, simplify logistics, and reduce operational risk. The same discipline that keeps transfer on schedule (defined assumptions, documented process intent, and early materials alignment) is what makes onshoring feasible without repeated rework. For more information, see our onshoring white paper, Seven Forces Driving Onshoring in Biologics Manufacturing: and our Onshoring Case Story.
- Analytical method readiness: phase-appropriate method qualification/validation, method transfer, and stability strategy.
- Comparability and change management: how to plan risk-based comparability when materials, scale, or site changes are introduced.
- Manufacturing readiness / MSAT: engineering run strategy, control strategy refinement, and GMP batch record development.
- Single-use and supply chain: materials qualification, lead-time planning, and supplier change control.
- Quality systems: deviation management, investigations, and documentation best practices that keep execution predictable.
Next steps: translate knowledge into an executable transfer plan
When you treat tech transfer as a structured program—rather than a last-minute handoff—you gain clarity on the true critical path and reduce the risk of late surprises. If you’re planning a site change, scaling from development into GMP, or aligning a new manufacturing network as part of an onshoring strategy, Avid can help define transfer success criteria, build the data package, and execute against a timeline that supports your IND and early clinical supply needs.
